Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model.
OBJECTIVE
The aims of this study were to verify that tissue-type plasminogen activator given either 1 or 2 hours after experimental embolic stroke in rabbits diminishes the volume of resulting ischemic brain and to ascertain the effect of the simultaneous administration of heparin.


METHODS
We embolized the middle cerebral artery of rabbits by injecting performed autologous arterial ("white") thrombus into one internal carotid artery. Treatment with 2 mg/kg tissue-type plasminogen activator, alone or in combination with heparin, was commenced either 1 or 2 hours after embolization. The animals were killed 5 hours after treatment commenced, and their brains were examined for evidence of ischemia and hemorrhage.


RESULTS
Administration of tissue-type plasminogen activator significantly diminished the size of the resulting brain ischemia. Administration of heparin, with or instead of tissue-type plasminogen activator, did not result in a significant decrease in the volume of cerebral ischemia, but it also did not lead to hemorrhagic transformation of the stroke.


CONCLUSIONS
In the rabbit model, administration of tissue-type plasminogen activator within 2 hours diminished the volume of brain rendered acutely ischemic by embolic stroke. Since the simultaneous administration of heparin during this same period did not result in any instances of hemorrhagic transformation, tissue-type plasminogen activator may have some place for use in such circumstances to mitigate a tendency to further embolic or thrombotic events.
Carter
L P
LP
Department of Surgery (Section of Neurosurgery), University of Arizona, Tucson.
Guthkelch
A N
AN
Orozco
J
J
Temeltas
O
O
D000704:Analysis of Variance; D000818:Animals; D001921:Brain / Q000473:pathology; D002545:Brain Ischemia / Q000097:blood / Q000175:diagnosis / Q000473:pathology*; D002561:Cerebrovascular Disorders / Q000473:pathology; D005260:Female; D006493:Heparin / Q000494:pharmacology*; D002542:Intracranial Embolism and Thrombosis / Q000473:pathology; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D010314:Partial Thromboplastin Time; D011817:Rabbits; D010959:Tissue Plasminogen Activator / Q000494:pharmacology*
D006493:Heparin; D010959:Tissue Plasminogen Activator